Register to chat with like-minded investors on our interactive forums.

Get Started

ABBV

AbbVie (ABBV)

AbbVie Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 Next >>

Date	Time	Source	Headline	Symbol	Company
12/18/2019	2:56PM	PR Newswire (Canada)	AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for the Combination VENCLEXTA® With Rituxim...	NYSE:ABBV	AbbVie Inc
12/18/2019	2:55PM	PR Newswire (Canada)	AbbVie conclut une entente avec l'Alliance pancanadienne pharmaceutique (APP) pour l'emploi de VENCLEXTA® en association ave...	NYSE:ABBV	AbbVie Inc
12/18/2019	11:37AM	Dow Jones News	AbbVie Gets EC Approval of Rinvoq for Adults With Rheumatoid Arthritis	NYSE:ABBV	AbbVie Inc
12/18/2019	10:50AM	PR Newswire (US)	AbbVie Receives European Commission Approval of RINVOQ™ (upadacitinib) for the Treatment of Adults with Moderate to Severe ...	NYSE:ABBV	AbbVie Inc
12/18/2019	10:22AM	Dow Jones News	Form 8.3 - Allergan Plc	NYSE:ABBV	AbbVie Inc
12/17/2019	10:02AM	Dow Jones News	Form 8.3 - [Allergan plc]	NYSE:ABBV	AbbVie Inc
12/16/2019	9:53AM	Dow Jones News	Form 8.3 - [Allergan plc]	NYSE:ABBV	AbbVie Inc
12/13/2019	9:55AM	Dow Jones News	Form 8.3 - [Allergan plc]	NYSE:ABBV	AbbVie Inc
12/12/2019	10:09AM	Dow Jones News	Form 8.3 - Allergan Plc	NYSE:ABBV	AbbVie Inc
12/11/2019	9:35AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
12/10/2019	9:58AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
12/09/2019	9:53AM	Dow Jones News	Form 8.3 - [Allergan plc]	NYSE:ABBV	AbbVie Inc
12/09/2019	8:00AM	GlobeNewswire Inc.	Adaptive and AbbVie Partner Across Multiple Myeloma Trials to Measure Minimal Residual Disease Using the clonoSEQ® Assay	NYSE:ABBV	AbbVie Inc
12/09/2019	8:00AM	PR Newswire (US)	AbbVie and Scripps Research announce collaboration to develop a broad range of new therapeutics	NYSE:ABBV	AbbVie Inc
12/08/2019	7:30AM	PR Newswire (US)	New Long-Term Data Continues to Demonstrate Progression-Free Survival and Overall Survival Benefits with VENCLEXTA®/ VENCLYX...	NYSE:ABBV	AbbVie Inc
12/07/2019	9:00AM	PR Newswire (US)	More than Seven-Year Analysis of Early Treatment with IMBRUVICA® (ibrutinib) Monotherapy Showed Improved Progression-Free Su...	NYSE:ABBV	AbbVie Inc
12/07/2019	7:33AM	PR Newswire (US)	Extended Follow-up Phase 3 Data Underscore Sustained Efficacy and Safety of IMBRUVICA® (ibrutinib) in the Treatment of Chron...	NYSE:ABBV	AbbVie Inc
12/07/2019	7:30AM	PR Newswire (US)	IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Combination Data Show High Rates of Disease Clearance in Pr...	NYSE:ABBV	AbbVie Inc
12/06/2019	4:30PM	GlobeNewswire Inc.	Alector Announces Phase 1 Data on AL002 at the 12th Clinical Trials on Alzheimer’s Disease (CTAD) Meeting	NYSE:ABBV	AbbVie Inc
12/06/2019	9:49AM	Dow Jones News	Form 8.3 - [Allergan plc]	NYSE:ABBV	AbbVie Inc
12/06/2019	6:08AM	PR Newswire (Canada)	AbbVie conclut une entente avec l'Alliance pancanadienne pharmaceutique (APP) relativement à SKYRIZI[MC] (risankizumab) pour...	NYSE:ABBV	AbbVie Inc
12/06/2019	6:08AM	PR Newswire (Canada)	AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for SKYRIZI™ (risankizumab) for the Treatm...	NYSE:ABBV	AbbVie Inc
12/05/2019	9:39AM	Dow Jones News	Form 8.3 - [Allergan plc]	NYSE:ABBV	AbbVie Inc
12/04/2019	9:54AM	Dow Jones News	Form 8.3 - Allergan Plc	NYSE:ABBV	AbbVie Inc
12/03/2019	10:43AM	Dow Jones News	Form 8.3 - Allergan Plc	NYSE:ABBV	AbbVie Inc
12/02/2019	9:59AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
11/27/2019	10:04AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
11/26/2019	10:07AM	Dow Jones News	Form 8.3 - Allergan Plc	NYSE:ABBV	AbbVie Inc
11/25/2019	9:13AM	Dow Jones News	Form 8.3 - [Allergan plc]	NYSE:ABBV	AbbVie Inc
11/22/2019	10:03AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 Next >>

Ethema Health (PK)

Digital Brand Media and ... (PK)

Northwest Biotherapeutics (QB)

Kraig Biocraft Laborator... (QB)

Fannie Mae (QB)

Anavex Life Sciences

Lightwave Logic

Intergrated Cannabis Sol... (PK)

Rennova Health (PK)

RespireRx Pharmaceuticals (PK)

Elite Pharmaceuticals (QB)

Net Savings Link (PK)

Delayed Upgrade Clock